• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recallsee related information
Date Initiated by FirmAugust 31, 2005
Date PostedOctober 06, 2005
Recall Status1 Terminated 3 on March 16, 2012
Recall NumberZ-0007-06
Recall Event ID 33412
510(K)NumberK042676 
Product Classification System, Test, Human Chorionic Gonadotropin - Product Code DHA
ProductHyperglycosylated Human Chorionic Gonadotropin (H-hCG) Assay Cartridges (Catalog#62-7039)
Code Information Lot #62-500262
FEI Number 2050095
Recalling Firm/
Manufacturer
Nichols Institute Diagnostics
1311 Calle Batido
San Clemente CA 92673-6316
For Additional Information ContactJohn Chiechi
949-940-7377
Manufacturer Reason
for Recall
Data from internal testing indicates that the Nichols Advantage Invasive Trophoblast Antigen Assay Cartridges (ITA)(Lot No 62-500261) and Hyperglycosylated Human Chorionic Gonadotropin Assay Cartridges (H-hCG)(Lot No 62-500262) does not maintain its stability over the 12 month expiration dating of the product, and that stability is assured only through 6 months.
FDA Determined
Cause 2
Other
ActionWithdrawal letter was sent 08/30/2005 which request customers to stop using the product immediately and discard any remaining materials. A response card was included.
Quantity in Commerce174
DistributionNationwide and China, Germany, & Australia
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = DHA
-
-